How to Get a Biotech Education Without Going to Medical School

Last week, while biotech stocks across the board were getting creamed, Biomatrix (BXM Quote) managed to squeeze out a two-point intraday gain. The gain, which vanished in trading this week, resulted from the Food and Drug Administration's preliminary approval for the company's HylaSine product.

Basically, HylaSine is a kind of goo doctors insert in your sinuses during surgery to minimize bleeding. Medicinal goos of any kind rarely trip people's triggers. Biomatrix's modest move last week, however, illustrates an important point.

The entire biotechnology arena is full of arcane products such as HylaSine that'll never cure AIDS or cancer or even the flu. But they do make profits and move stocks. And if you want to be successful as a biotech investor, you'd best learn about them. ...